Stay in touch with NCATS by connecting via social media, joining our listserv for frequent announcements, and subscribing to our monthly e-newsletter.
Explore the full spectrum of translational science, including NCATS' role in transforming knowledge into treatments.
Review a list of all the innovative programs and initiatives that NCATS supports.
NCATS’ TRND program is supporting two natural history studies on how specific rare diseases progress over time.
CTSA Program-supported scientists work to develop novel technique to test drugs against the most common form of brain cancer.
Read about a promising new gene therapy for a rare condition, CTSA Program-supported brain cancer drug testing, NIH’s latest awards for Tissue Chip research, and more.
NCATS announced 13 awards to develop 3-D tissue chip research platforms that model disease and test drug efficacy prior to clinical trials.
Join NCATS on Oct. 25, 2017, to learn more about the progress being made on constructing the biomedical data translator.
NCATS launched an online resource portal to help patient support organizations
NCATS and Agilis researchers collaborated on a gene therapy for a rare pediatric condition
Christopher P. Austin, M.D.
Funded activities under the NCATS Clinical and Translational Science Awards (CTSA) Program (PDF - 370KB)
Interested in creating biologically, physiologically and pharmacologically relevant assays for early-stage drug discovery? Check out our best-practices Assay Guidance Manual.
Learn more about all the ways that potential grantees, partners and collaborators can access NCATS support to advance translational science.
More News & Events …